Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.

OBJECTIVES: The aim of this study was to assess the relationship between systemic inflammation, atherosclerosis, and thrombosis in two distinct clinical models of atherothrombosis. BACKGROUND: Persistent unstable angina (UA) is commonly associated with coronary thrombosis and persistent systemic in...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Monaco, C, Rossi, E, Milazzo, D, Citterio, F, Ginnetti, F, D'Onofrio, G, Cianflone, D, Crea, F, Biasucci, L, Maseri, A
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2005
_version_ 1826279652736368640
author Monaco, C
Rossi, E
Milazzo, D
Citterio, F
Ginnetti, F
D'Onofrio, G
Cianflone, D
Crea, F
Biasucci, L
Maseri, A
author_facet Monaco, C
Rossi, E
Milazzo, D
Citterio, F
Ginnetti, F
D'Onofrio, G
Cianflone, D
Crea, F
Biasucci, L
Maseri, A
author_sort Monaco, C
collection OXFORD
description OBJECTIVES: The aim of this study was to assess the relationship between systemic inflammation, atherosclerosis, and thrombosis in two distinct clinical models of atherothrombosis. BACKGROUND: Persistent unstable angina (UA) is commonly associated with coronary thrombosis and persistent systemic inflammation. METHODS: We assessed circulating markers of activation of the thrombotic and fibrinolytic cascades and systemic soluble and cellular markers of inflammation on admission in 40 patients with persisting UA (Braunwald class IIIB; group 1) and 30 patients with Leriche-Fontaine stage IIB-III peripheral artery disease awaiting revascularization (group 2). RESULTS: The extent of atherosclerosis (p < 0.01) and activation of the coagulation system were greater in group 2, which had higher thrombin-antithrombin III complexes and D-dimer levels (2.7 and 24.4 microg/l, respectively), than in group 1 (2.0 microg/l and 12.9 microg/l, p = 0.02 and p = 0.0001, respectively). In contrast, C-reactive protein and interleukin-6 levels were higher in group 1 (7.6 pg/ml and 7.8 pg/ml, respectively) than in group 2 (4.5 pg/ml and 3.0 pg/ml, p < 0.01 and p = 0.03, respectively). Moreover, neutrophil activation was only found in group 1 (neutrophil myeloperoxidase content -4.0 arbitrary units vs. +3.4 arbitrary units in group 2, p < 0.0001). These differences persisted during the initial three days of hospitalization. CONCLUSIONS: Such a large, consistent discrepancy between atherothrombotic burden and systemic inflammation suggests that atherothrombosis, by itself, is an unlikely cause of persisting, recurring UA. An understanding of the primary inflammatory mechanisms of persistent and recurrent coronary instability could open the way to novel therapeutic strategies.
first_indexed 2024-03-07T00:01:58Z
format Journal article
id oxford-uuid:7643cfcc-0b10-4f6c-82c6-3535c5755dc0
institution University of Oxford
language English
last_indexed 2024-03-07T00:01:58Z
publishDate 2005
record_format dspace
spelling oxford-uuid:7643cfcc-0b10-4f6c-82c6-3535c5755dc02022-03-26T20:14:42ZPersistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7643cfcc-0b10-4f6c-82c6-3535c5755dc0EnglishSymplectic Elements at Oxford2005Monaco, CRossi, EMilazzo, DCitterio, FGinnetti, FD'Onofrio, GCianflone, DCrea, FBiasucci, LMaseri, A OBJECTIVES: The aim of this study was to assess the relationship between systemic inflammation, atherosclerosis, and thrombosis in two distinct clinical models of atherothrombosis. BACKGROUND: Persistent unstable angina (UA) is commonly associated with coronary thrombosis and persistent systemic inflammation. METHODS: We assessed circulating markers of activation of the thrombotic and fibrinolytic cascades and systemic soluble and cellular markers of inflammation on admission in 40 patients with persisting UA (Braunwald class IIIB; group 1) and 30 patients with Leriche-Fontaine stage IIB-III peripheral artery disease awaiting revascularization (group 2). RESULTS: The extent of atherosclerosis (p < 0.01) and activation of the coagulation system were greater in group 2, which had higher thrombin-antithrombin III complexes and D-dimer levels (2.7 and 24.4 microg/l, respectively), than in group 1 (2.0 microg/l and 12.9 microg/l, p = 0.02 and p = 0.0001, respectively). In contrast, C-reactive protein and interleukin-6 levels were higher in group 1 (7.6 pg/ml and 7.8 pg/ml, respectively) than in group 2 (4.5 pg/ml and 3.0 pg/ml, p < 0.01 and p = 0.03, respectively). Moreover, neutrophil activation was only found in group 1 (neutrophil myeloperoxidase content -4.0 arbitrary units vs. +3.4 arbitrary units in group 2, p < 0.0001). These differences persisted during the initial three days of hospitalization. CONCLUSIONS: Such a large, consistent discrepancy between atherothrombotic burden and systemic inflammation suggests that atherothrombosis, by itself, is an unlikely cause of persisting, recurring UA. An understanding of the primary inflammatory mechanisms of persistent and recurrent coronary instability could open the way to novel therapeutic strategies.
spellingShingle Monaco, C
Rossi, E
Milazzo, D
Citterio, F
Ginnetti, F
D'Onofrio, G
Cianflone, D
Crea, F
Biasucci, L
Maseri, A
Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title_full Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title_fullStr Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title_full_unstemmed Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title_short Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
title_sort persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden
work_keys_str_mv AT monacoc persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT rossie persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT milazzod persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT citteriof persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT ginnettif persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT donofriog persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT cianfloned persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT creaf persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT biasuccil persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden
AT maseria persistentsystemicinflammationinunstableanginaislargelyunrelatedtotheatherothromboticburden